May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Low Dose, Subconjunctival Administration of VEGF Trap Inhibits Suture–Induced Corneal Neovascularization and Inflammation
Author Affiliations & Notes
  • Y. Liu
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • J. Cao
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • R.A. Renard
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • H. Song
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • D. Hylton
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • J.S. Rudge
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • N. Papadopoulos
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • G.D. Yancopoulos
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • S.J. Wiegand
    Eye Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  • Footnotes
    Commercial Relationships  Y. Liu, Regeneron Pharmaceuticals, Inc., E; J. Cao, Regeneron Pharmaceuticals, Inc., E; R.A. Renard, Regeneron Pharmaceuticals, Inc., E; H. Song, Regeneron Pharmaceuticals, Inc., E; D. Hylton, Regeneron Pharmaceuticals, Inc., E; J.S. Rudge, Regeneron Pharmaceuticals, Inc., E; N. Papadopoulos, Regeneron Pharmaceuticals, Inc., E; G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc., E; S.J. Wiegand, Regeneron Pharmaceuticals, Inc., E.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1626. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Liu, J. Cao, R.A. Renard, H. Song, D. Hylton, J.S. Rudge, N. Papadopoulos, G.D. Yancopoulos, S.J. Wiegand; Low Dose, Subconjunctival Administration of VEGF Trap Inhibits Suture–Induced Corneal Neovascularization and Inflammation . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1626.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously reported that systemic administration of VEGF Trap markedly inhibited neovascularization in response to corneal injury in rodent models. The present study evaluates the effect of subconjunctival delivery of VEGF Trap at very low doses on the development of neovascularization following corneal suture injury.

Methods: : Corneal neovascularization (NV) was induced by intrastromal placement of three nylon sutures in adult male Sprague–Dawley rats. VEGF Trap was administered subconjunctivally at four doses (100 mcg, 50 mcg, 25 mcg, or 5 mcg in 50 mcL / eye) immediately after injury (day 0) and on days 3 and 6 post–injury. Control animals received injections of vehicle following the same schedule. The growth of corneal neovessels was evaluated in–life by slit–lamp microscopy. The corneal vasculature was labeled by intravenous injection of FITC conjugated Concavalin A, and the extent of NV was evaluated post–mortem in corneal flat–mounts. The Scion Image program was used to measure the length of corneal neovessels. Infiltration of leukocytes was observed in cross–sections stained with H&E. Serum levels of free VEGF Trap were determined by anti–VEGF Trap ELISA on day 9.

Results: : Subconjunctival administration of VEGF Trap significantly inhibited corneal neovascularization at all doses tested, though the extent of inhibition was dose dependent (97% to 82% inhibition). The infiltration of leukocytes also was attenuated. Systemic administration of VEGF Trap at the highest of the above doses (100 mcg on days 0, 3 and 6) did not inhibit corneal NV or infiltration of leukocytes. Unbound VEGF Trap was not detected in the serum following multiple subconjunctival injections.

Conclusions: : Subconjunctival administration of low dose of VEGF Trap suppresses the development of corneal neovascularization and reduces the infiltration of leukocytes into the cornea following injury, in the absence of appreciable systemic exposure.

Keywords: growth factors/growth factor receptors • neovascularization • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×